clinicaltrials.gov

Vir RSS za ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted

Q: Kateri je URL vira RSS za ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted?

Naslov vira je https://clinicaltrials.gov/api/rss?term=%28%22generalized+myasthenia+gravis%22+OR+%22myasthenia+gravis%22%29+AND+%28eculizumab+OR+ravulizumab+OR+gefurulimab+OR+inebilizumab+OR+nipocalimab+OR+zilucoplan+OR+rozanolixizumab+OR+efgartigimod+OR+remibrutinib%29&dateField=LastUpdatePostDate. Prilepite ga v kateri koli bralnik RSS ali kliknite Spremljaj zdaj, da ga boste brali v aplikaciji Feeder.

Q: Ali vir RSS ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted deluje?

Da. Feeder ga je preveril pred 4 minute in vir se je normalno odzval.

Q: Kako lahko spremljam ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted v aplikaciji Feeder?

Kliknite Spremljaj zdaj in se registrirajte, če še nimate računa. Brezplačni paket Feeder vključuje do 200 virov v spletu ter napravah iPhone in Android. Kreditna kartica ni potrebna.

Prejemaj najnovejše posodobitve iz ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted takoj, ko se zgodijo.

Spremljaj zdaj < 10 sledilcev

O tem viru

Studies found on ClinicalTrials.gov by a search of: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last updat...

Stanje: Deluje Preverjeno pred 4 minute, vsakih okoli 2 uri
Objave: Približno 5-krat na teden Zadnja objava pred 5 dni
Jezik: English
Sledilci: < 10
Spletno mesto: clinicaltrials.gov
URL vira RSS: https://clinicaltrials.gov/api/rss?term=%28%22generalized+myasthenia+gravis%22+OR+%22myasthenia+gravis%22%29+AND+%28eculizumab+OR+ravulizumab+OR+gefurulimab+OR+inebilizumab+OR+nipocalimab+OR+zilucoplan+OR+rozanolixizumab+OR+efgartigimod+OR+remibrutinib%29&dateField=LastUpdatePostDate

Preverite ta vir z validatorjem RSS

Poiščite vir RSS drugega spletnega mesta

Najnovejše objave

Berite ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted tam, kjer sicer berete

Sledite v aplikaciji Feeder Berite ga skupaj z vsem drugim, čemur sledite, v spletu, na iPhonu in v sistemu Android. E-poštni novičniki Svoje branje spremenite v novičnik, ne da bi zapustili Feeder. RSS v Telegram Vaši viri, dostavljeni na Telegram. Nahranite svojo umetno inteligenco Povežite Claude, ChatGPT in Cursor s svojimi viri prek MCP-ja Povzetki z AI Ujemite bistvo, z viri za preverjanje. Pretvorba besedila v govor Spremenite svoj bralni seznam v podcast.

Vprašanja

Kateri je URL vira RSS za ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted?

Naslov vira je https://clinicaltrials.gov/api/rss?term=%28%22generalized+myasthenia+gravis%22+OR+%22myasthenia+gravis%22%29+AND+%28eculizumab+OR+ravulizumab+OR+gefurulimab+OR+inebilizumab+OR+nipocalimab+OR+zilucoplan+OR+rozanolixizumab+OR+efgartigimod+OR+remibrutinib%29&dateField=LastUpdatePostDate. Prilepite ga v kateri koli bralnik RSS ali kliknite Spremljaj zdaj, da ga boste brali v aplikaciji Feeder.

Kako pogosto objavlja ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted?

ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted objavlja približno 5-krat na teden. Zadnja objava je bila objavljena pred 5 dni.

Ali vir RSS ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted deluje?

Da. Feeder ga je preveril pred 4 minute in vir se je normalno odzval.

Kako lahko spremljam ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted v aplikaciji Feeder?

Kliknite Spremljaj zdaj in se registrirajte, če še nimate računa. Brezplačni paket Feeder vključuje do 200 virov v spletu ter napravah iPhone in Android. Kreditna kartica ni potrebna.

Spremljajte ClinicalTrials.gov: Other terms: ("generalized myasthenia gravis" OR "myasthenia gravis") AND (eculizumab OR ravulizumab OR gefurulimab OR inebilizumab OR nipocalimab OR zilucoplan OR rozanolixizumab OR efgartigimod OR remibrutinib) | Last update posted v aplikaciji Feeder

Brezplačni paket Feeder vključuje do 200 virov v spletu ter napravah iPhone in Android. Kreditna kartica ni potrebna.

Prijavi se brezplačno

Ali pa se prijavite